Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model
Ditza Levin(Center for Biologics Evaluation and Research), Basil Golding(Center for Biologics Evaluation and Research), Erin Burch(Syngenta (United States)), Siyou Tan, Haiyan Jiang(Inner Mongolia Agricultural University), H. A. Daniel Lagassé(Center for Biologics Evaluation and Research), Zuben E. Sauna(Center for Biologics Evaluation and Research), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
Cited by 7
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
|Nature Medicine|2019|708
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548